相关实验视频
Updated: Sep 1, 2026

07:23
Improved Rodent Model of Myocardial Ischemia and Reperfusion Injury
Published on: March 7, 2022
5.9K
基于Si的药物通过抗氧化作用减轻了小肠缺血-再输液损伤
Masato Shimada1, Yoshihisa Koyama2,3,4,5, Yuki Kobayashi6
1Department of Neuroscience and Cell Biology, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita, Osaka, 565-0871, Japan.
Scientific reports
|February 20, 2024
概括
一种基于的新型抗氧化剂有效地治疗小肠道缺血-再输液 (IR) 损伤. 这种药物减少了细胞死亡,并保持了肠粘膜的厚度,为改善移植结果提供了潜在的机会.
科学领域:
- 生物医学工程 生物医学工程
- 胃肠病学 胃肠病学
- 再生医学是一种再生医学.
背景情况:
- 小肠缺血-再输液 (IR) 损伤导致细胞亡和潜在的肠功能丧失,需要进行治疗干预.
- 氧化应激是红外伤害进展的关键因素,突出了抗氧化剂作为治疗剂的潜力.
- 基于 (Si) 的药物已在各种疾病中表现出有效性,包括性结肠炎,功能衰竭和皮肤片中的IR损伤.
研究的目的:
- 在小肠IR损伤的小鼠模型中研究Si基抗氧化剂的疗效.
- 为了确定Si基剂是否可以减轻氧化应激,并保护肠道上皮细胞免受亡.
- 评估Si基剂对小肠粘膜的结构完整性的影响.
主要方法:
- 在小鼠模型中诱导小肠红外损伤.
- 这种基于Si的药物的口服.
- 评估小肠上皮细胞亡. 小肠上皮细胞亡.
- 测量小肠粘膜厚度的方法.
主要成果:
- 这种基于Si的药物显著抑制了小肠上皮细胞的亡.
- 在以Si为基础的药物治疗组中观察到氧化应激减少.
- 与对照组相比,在基于Si的药物治疗组中,观察到的粘膜层厚度显著增加.
结论:
- 这种基于Si的药物通过减少氧化应激和亡,显著有效地保护小肠的IR损伤.
- 保持粘膜完整性表明Si基剂在红外伤害中的治疗益处.
- 基于Si的药物有望改善小肠移植和管理IR损伤的结果.
相关概念视频
Drugs for Treatment of Constipation-Predominant IBS
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
Drugs for Treatment of Ulcerative Colitis in IBD
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide generation.

